In this presentation from the Lymphoma & Myeloma 2017, Dr. Adam D. Cohen discusses the future of multiple myeloma therapy, with a specific focus on BITE immunotherapy, CAR-T, and immune checkpoint inhibitors.

Earn CME credit for a related activity at the following location:

© 2017 Imedex, LLC.

Leave a Reply

Let us help fight cancer. Share your knowledge.


Latest news, views, insights and trends on cancer treatment, discovery and support